A. Scott Pierson

1.1k citations
8 papers · 412 indexed · h-index 8
Topics
Cancer Treatment and Pharmacology (4 papers)Cancer therapeutics and mechanisms (3 papers)Angiogenesis and VEGF in Cancer (2 papers)
Partner nations
United States

In The Last Decade

A. Scott Pierson

8 papers receiving 400 citations

Peers

A. Scott Pierson
Comparison fields: 5 of 64
  • Molecular Biology 227
  • Pulmonary and Respiratory Medicine 199
  • Oncology 107
  • Pharmacology 103
  • Pharmacology 83
Replace Weili Min with:
Weili Min China
Radka Václavíková Czechia
Sheng‐Zhang Lin China
Shinichiro Yoshitani Japan
Pablo Cano Canada
Xiaonan Xi China
Tung‐Kwang Lee United States
Yu‐Hsuan Lan Taiwan
Fengjun Cao China
Zhonghuang Li China
A. Scott Pierson relative to Weili Min China Weili Min's profile →
Citations per field
00.5×1.5×2.2×
Weili Min · 1×
Citations per year

Countries citing papers authored by A. Scott Pierson

Since Specialization
Citations

This map shows the geographic impact of A. Scott Pierson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Scott Pierson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Scott Pierson more than expected).

Fields of papers citing papers by A. Scott Pierson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Scott Pierson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Scott Pierson. The network helps show where A. Scott Pierson may publish in the future.

Co-authorship network of co-authors of A. Scott Pierson

This figure shows the co-authorship network connecting the top 25 collaborators of A. Scott Pierson. A scholar is included among the top collaborators of A. Scott Pierson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Scott Pierson. A. Scott Pierson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
#WorkIndexed citations
1 7
2 264
3 13
4 22
5 50
6 37
7 11
8
Therapeutic angiogenesis inhibitors in the treatment of cancer.
8

About A. Scott Pierson

A. Scott Pierson is a scholar working on Oncology, Hepatology and Pharmacology, having authored 8 papers that have together received 412 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (3 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Pharmacology (83 citations), Pharmacology (103 citations) and Pulmonary and Respiratory Medicine (199 citations). A. Scott Pierson has collaborated with scholars based in United States. Frequent co-authors include Daniel L. Gustafson, Joseph A. Zirrolli, L. Michael Glodé, Thomas W. Flaig, Gail S. Harrison, Rajesh Agarwal, Lih‐Jen Su, Frances Crighton, Scott N. Holden and Sabine Eckhardt. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology and Cancer Chemotherapy and Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026